London, United Kingdom – 23rd May, 2025 Axis MedTech (Holdings) Limited (“Axis MedTech” or “the Company”) is pleased to announce it has acquired 3,300,000 new ordinary shares of 0.01 pence in TruSpine Technologies plc (“TruSpine”) at a price of 1.5 pence per share (“Subscription Shares”), raising gross proceeds of £49,500 (“Subscription”).
In addition, Geoff Miller has exchanged his £136,573 TruSpine convertible loan notes (“CLN”) in the Company for 136,573 new ordinary shares in Axis MedTech (“CLN Disposal”).
This transaction is the second in what is expected to be a series of transactions by Axis MedTech, designed to build a substantial MedTech business over a series of verticals, capable of delivering material improvements to patient outcomes on a globally significant level.
With today’s transactions the Axis MedTech stake, on a fully diluted basis, amounts to 7.2% of TruSpine. It is expected that Axis MedTech will increase its stake in TruSpine over time.
About TruSpine Technologies Plc
TruSpine Technologies Plc is a medical device company focused on the spinal (vertebral) stabilisation market.
The Company is developing disruptive technologies for use in the spinal stabilisation market, commencing with the following three devices:
- Cervi-LOK - for the cervical and upper thoracic spine
- Faci-LOK - for the lumbar and lower thoracic spine, and
- GRASP Laminoplasty - a treatment for decompression of the spinal cord.
These devices represent a potentially significant development in spinal fixation, by providing stabilisation while not altering the bony spinal anatomy of patients through the use of screws, staples or other devices which currently dominate the spinal market.
About Axis MedTech
Axis-MedTech was established to address a key structural inefficiency within the Life Sciences sector - where groundbreaking innovation and entrepreneurial energy often outpace the strategic frameworks needed to support long-term growth. This dynamic presents an opportunity to contribute positively to the ecosystem by providing guidance, resources, and operational support to help promising ventures reach their full potential.
In today’s evolving industry landscape, Axis-MedTech partners with companies that possess exceptional intellectual property but require enhanced strategic alignment and capital stewardship. Through thoughtful collaboration and the application of decades of proven management expertise, Axis-MedTech aims to unlock value, empower key innovators, and build a portfolio of globally impactful health and wellness businesses for the benefit of all stakeholders.
Media Contact : Geoff.miller@axis-medtech.com
